Cerity Partners LLC Cybin Inc. Transaction History

Cerity Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.26 - $0.46 $5,460 - $9,660	-21,000 Reduced 24.92%	63,271 $17,000
Q1 2024 May 14, 2024	SELL	$0.3 - $0.46 $1,200 - $1,840	-4,000 Reduced 4.53%	84,271 $34,000
Q4 2023 Jan 26, 2024	BUY	$0.38 - $0.65 $27,842 - $47,626	73,271 Added 488.47%	88,271 $36,000
Q3 2023 Nov 13, 2023	SELL	$0.29 - $0.63 $15,804 - $34,335	-54,500 Reduced 78.42%	15,000 $7,000
Q2 2023 Aug 14, 2023	BUY	$0.23 - $0.39 $4,830 - $8,190	21,000 Added 43.3%	69,500 $26,000
Q4 2022 Feb 15, 2023	SELL	$0.26 - $0.64 $2,860 - $7,040	-11,000 Reduced 18.49%	48,500 $14,000
Q3 2022 Nov 10, 2022	BUY	$0.48 - $1.11 $28,560 - $66,045	59,500 New	59,500 $29,000

66.1K

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $1.65B
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Cerity Partners LLC with notifications on news.